Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Lowe

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Annals of Surgical Oncology|November 22, 2017
Morbidity and Outcomes Following Axillary Lymphadenectomy for Melanoma: Weighing the Risk of Surgery in the Era of MSLT-IILauren M Postlewait, Clara R Farley, Alexandra M Seamens, et al.
The American Surgeon|September 25, 2009
Important prognostic factors in adenocarcinoma of the ampulla of VaterMichael C Lowe, Ipek Coban, N Volkan Adsay, et al.
Science Translational Medicine|August 23, 2023
FcγRIIB expressed on CD8<sup>+</sup> T cells limits responsiveness to PD-1 checkpoint inhibition in cancerKelsey B Bennion, Marvi Tariq, Megan M Wyatt, et al.
Journal of Surgical Oncology|September 17, 2022
Regional control after precision lymph node dissection for clinically evident melanoma metastasisKevin T Lynch, Yinin Hu, Norma E Farrow, et al.
Cancer Medicine|May 24, 2022
Impact of concomitant fibrates on immunotherapy outcomes for advanced non-small cell lung cancerWilliam A Stokes, Madhusmita Behera, Renjian Jiang, et al.
The Oncologist|September 25, 2024
The association of azole antifungals with overall survival in patients with non-small cell lung cancer receiving immune checkpoint inhibitorsNikhil T Sebastian, William A Stokes, Madhusmita Behera, et al.
Clinical Lung Cancer|February 22, 2023
The Association of Improved Overall Survival with NSAIDs in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint InhibitorsNikhil T Sebastian, William A Stokes, Madhusmita Behera, et al.
Journal of Virology|March 27, 2023
HIV-1 DNA and Immune Activation Levels Differ for Long-Lived T-Cells in Lymph Nodes, Compared with Peripheral Blood, during Antiretroviral TherapyChristina Mallarino-Haeger, Maria Pino, Elise G Viox, et al.
Journal for Immunotherapy of Cancer|March 26, 2024
Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysisJimmy S Patel, Yena Woo, Amber Draper, et al.
Journal of Cancer Research and Clinical Oncology|December 30, 2025
Subgroup analyses of the phase 3 FOCUS study of melphalan/hepatic delivery system in patients with unresectable metastatic uveal melanomaJonathan S Zager, Marlana Orloff, Pier Francesco Ferrucci, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Annals of Surgical Oncology|November 22, 2017
Morbidity and Outcomes Following Axillary Lymphadenectomy for Melanoma: Weighing the Risk of Surgery in the Era of MSLT-IILauren M Postlewait, Clara R Farley, Alexandra M Seamens, et al.
The American Surgeon|September 25, 2009
Important prognostic factors in adenocarcinoma of the ampulla of VaterMichael C Lowe, Ipek Coban, N Volkan Adsay, et al.
Science Translational Medicine|August 23, 2023
FcγRIIB expressed on CD8<sup>+</sup> T cells limits responsiveness to PD-1 checkpoint inhibition in cancerKelsey B Bennion, Marvi Tariq, Megan M Wyatt, et al.
Journal of Surgical Oncology|September 17, 2022
Regional control after precision lymph node dissection for clinically evident melanoma metastasisKevin T Lynch, Yinin Hu, Norma E Farrow, et al.
Cancer Medicine|May 24, 2022
Impact of concomitant fibrates on immunotherapy outcomes for advanced non-small cell lung cancerWilliam A Stokes, Madhusmita Behera, Renjian Jiang, et al.
The Oncologist|September 25, 2024
The association of azole antifungals with overall survival in patients with non-small cell lung cancer receiving immune checkpoint inhibitorsNikhil T Sebastian, William A Stokes, Madhusmita Behera, et al.
Clinical Lung Cancer|February 22, 2023
The Association of Improved Overall Survival with NSAIDs in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint InhibitorsNikhil T Sebastian, William A Stokes, Madhusmita Behera, et al.
Journal of Virology|March 27, 2023
HIV-1 DNA and Immune Activation Levels Differ for Long-Lived T-Cells in Lymph Nodes, Compared with Peripheral Blood, during Antiretroviral TherapyChristina Mallarino-Haeger, Maria Pino, Elise G Viox, et al.
Journal for Immunotherapy of Cancer|March 26, 2024
Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysisJimmy S Patel, Yena Woo, Amber Draper, et al.
Journal of Cancer Research and Clinical Oncology|December 30, 2025
Subgroup analyses of the phase 3 FOCUS study of melphalan/hepatic delivery system in patients with unresectable metastatic uveal melanomaJonathan S Zager, Marlana Orloff, Pier Francesco Ferrucci, et al.
Pageof 5